LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 1,197,576 Value ($000) $1,653 Avg Close — Range —
Q2 2024
Shares 985,336 Value ($000) $1,429 Avg Close — Range —
Q1 2024
Shares 236,754 Value ($000) $528 Avg Close — Range —
Q3 2022
Shares 33,490 Value ($000) $245 Avg Close — Range —
Q1 2022
Shares 67,756 Value ($000) $342 Avg Close — Range —
Q3 2021
Shares 128,535 Value ($000) $1,902 Avg Close — Range —